Xtant Medical to earn $15M in stock sale

Xtant Medical Holdings, a medical device company focused on surgical solutions for the spine, has agreed to sell 20 million shares of common stock to an investor, resulting in gross proceeds of $15 million, according to a July 3 report from Market Screener. 

Advertisement

Xtant plans to use the proceeds for working capital and other general corporate purposes, according to the report. The sales closed July 6. 

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spine

Advertisement

Comments are closed.